Trials / Active Not Recruiting
Active Not RecruitingNCT01153035
Excision Followed by Radiofrequency Ablation for Breast Cancer
ABLATE Registry: Radiofrequency Ablation After Breast Lumpectomy (eRFA) Added To Extend Intraoperative Margins in the Treatment of Breast Cancer
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- University of Arkansas · Academic / Other
- Sex
- Female
- Age
- 50 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer lumpectomy sites to extend the "final" negative margin and consequently decrease the rates of re-operation. During the initial breast conservation procedure (lumpectomy), immediately following routine surgical resection of the tumor, radiofrequency energy (RFA) is applied to the wall (bed) of the fresh lumpectomy cavity, thus extending tumor free margin radially beyond the volume of the resected specimen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Radiofrequency Ablation | Breast conservation surgery followed by Radiofrequency Ablation of the cavity |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2027-06-01
- Completion
- 2027-06-01
- First posted
- 2010-06-29
- Last updated
- 2025-11-10
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01153035. Inclusion in this directory is not an endorsement.